Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
DemeRx Announces FDA Acceptance of IND Application to Advance DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
changes
News beats
23 Jun at 10:25 am
Read Article
Next Post
DemeRx Taps Michael Snitkovsky as New COO
Previous Post
Commissioner’s National Priority Voucher (CNPV) Pilot Program
Menu
